MedPath
TGA Approval

EPYZTEK ustekinumab 5 mg/1 mL solution for intravenous infusion injection vial (423023)

423023

EPYZTEK ustekinumab 5 mg/1 mL solution for intravenous infusion injection vial

Samsung Bioepis AU Pty Ltd

October 21, 2024

Medicine

Medicine

Active

Registered

Active Ingredients

Ustekinumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.